Ossian, IN, Feb. 24, 2023 — MCapMediaWire — Freedom Holdings, Inc. aka Freedom Acquisition Corp (OTC: FHLD) (“FHLD” or the “Company”), is pleased to announce the new management’s long-term goal in the cannabis arena which completes our plan to re-structuring the company with a productive reorganization in the Cannabis arena.
With MEDcann, Inc. as our new majority owned shareholder, the Company is a Medical Cannabis Company focusing on Beverage manufacturing under 420 Beverages which is partners with a 420 – 215 licensed company called the Medical Cannabis, Inc. a subsidiary of MedCann. We are focusing on Research, in medical beverages, overseeing product manufacturing and sales. Our divisions in the cannabis industry, along with their associated products in the medical and health industries plans to Grow, Cultivate, Research and Manufacture CBD and THC beer and soft drinks in the medical marijuana industry with products that help a variety of maladies.
Our intent is to conduct and pass Clinical Trials pursuant to offer the credibility needed so we can obtain FDA and Patient Recognition. Since there are over 1000 chemicals in each strain of cannabis it maybe next to impossible to get approval, but we plan to set a precedence and mark the new beginning of history by opening the doors to recognition of the potential future for patient curiosity and satisfaction in treating cancer and the associated pain that accompanies the devastating condition.
FDA approval will afford us the ability to pursue Insurance company acceptable to support patient access to our VCO (Visita Care Oil) a remake of the RSO (Rick Simpson Oil). RSO is a cannabis concentrate used for many different medical benefits, including relieving cancer symptoms.
Press Release Contact:
Freedom Holdings, Inc.
Safe Harbor Statement
This press release contains statements, which may constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief, or current expectations of the Company, members of its management, and assumptions on which such statements are based. We caution prospective investors that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements.